IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.
If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!
Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.
Company: Amicus Therapeutics, Inc.
Symbol: FOLD
Price: Last Trade $13.17
Trade Date: 7/13
Re-offer Range: Subscription Needed
Shares: 17.1 million ($225 million cash raise)
Underwriter(s) : J.P. Morgan, Goldman Sachs & Co.
Co-Manager(s): BofA Merrill Lynch, Cowen and Company
Rating = Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish